Brought to you by 
Opexa Therapeutics closes $12.8mm rights offering
10 Apr 2015
Executive Summary
Opexa Therapeutics Inc. (personalized immunotherapies) netted $12.8mm through a rights offering by issuing 25.1mm units (including oversubscriptions) at $0.55. (Stockholders subscribed to a total of 25.1mm shares.)
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Other
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Opexa Therapeutics closes $12.8mm rights offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice